Annual report 2023*

14 Leases

Lease assets

 

 

2023

millions of CHF

 

Land and buildings, leased

 

Machinery and technical equipment, leased

 

Other non-current assets, leased

 

Total

Balance as of January 1

 

53.5

 

17.6

 

1.0

 

72.1

Acquired through business combination

 

1.6

 

1.6

Additions

 

7.0

 

5.0

 

0.3

 

12.3

Depreciation

 

–7.3

 

–1.9

 

–0.4

 

–9.5

Remeasurements and contract modifications

 

0.3

 

 

 

0.3

Currency translation differences

 

–2.2

 

–0.6

 

–0.0

 

–2.8

Total lease assets as of December 31

 

53.0

 

20.1

 

0.8

 

73.9

 

 

2022

millions of CHF

 

Land and buildings, leased

 

Machinery and technical equipment, leased

 

Other non-current assets, leased

 

Total

Balance as of January 1

 

46.6

 

18.4

 

1.3

 

66.2

Deconsolidation of medmix Poland

 

–3.2

 

–1.6

 

 

–4.8

Additions

 

17.9

 

2.9

 

0.3

 

21.1

Disposals

 

–0.0

 

–0.0

 

–0.0

 

–0.0

Depreciation

 

–6.6

 

–1.4

 

–0.5

 

–8.5

Remeasurements and contract modifications

 

0.2

 

 

 

0.2

Currency translation differences

 

–1.3

 

–0.7

 

–0.1

 

–2.1

Total lease assets as of December 31

 

53.5

 

17.6

 

1.0

 

72.1

Lease liabilities

 

 

2023

millions of CHF

 

Non-current lease liabilities

 

Current lease liabilities

 

Total

Balance as of January 1

 

62.5

 

9.0

 

71.5

Additions

 

10.0

 

2.3

 

12.3

Interest expenses

 

1.1

 

0.2

 

1.3

Cash flow for repayments – principal portion

 

–0.0

 

–10.4

 

–10.4

Cash flow for repayments – interest portion

 

–1.1

 

–0.2

 

–1.3

Remeasurements and contract modifications

 

0.3

 

 

0.3

Reclassifications

 

–10.2

 

10.2

 

Currency translation differences

 

–2.4

 

–0.4

 

–2.8

Total lease liabilities as of December 31

 

60.2

 

10.7

 

70.9

 

 

2022

millions of CHF

 

Non-current lease liabilities

 

Current lease liabilities

 

Total

Balance as of January 1

 

57.8

 

7.9

 

65.7

Deconsolidation of medmix Poland

 

–3.4

 

–1.1

 

–4.5

Additions

 

19.3

 

1.8

 

21.1

Interest expenses

 

0.9

 

0.1

 

1.0

Cash flow for repayments – principal portion

 

–0.4

 

–8.4

 

–8.9

Cash flow for repayments – interest portion

 

–0.9

 

–0.1

 

–1.0

Remeasurements and contract modifications

 

0.2

 

 

0.2

Reclassifications

 

–9.2

 

9.2

 

Currency translation differences

 

–1.9

 

–0.3

 

–2.1

Total lease liabilities as of December 31

 

62.5

 

9.0

 

71.5

Other leasing disclosures

millions of CHF

 

2023

 

2022

Recognized in the income statement

 

 

 

 

Expenses relating to short-term leases

 

–1.7

 

–1.1

Expenses relating to low-value asset leases, excluding short-term leases of low-value assets

 

–0.1

 

–0.2

Expenses relating to variable lease payments not included in the lease liability

 

–0.3

 

–0.3

Income from subleasing right-of-use assets

 

0.9

 

0.1

Interest expenses on lease liabilities

 

–1.3

 

–1.0

Total recognized in the income statement

 

–2.6

 

–2.5

 

 

 

 

 

Recognized in the statement of cash flows

 

 

 

 

Cash flow for short-term, low-value and variable leases (included within cash flow from operating activities)

 

–2.2

 

–1.6

Cash flow from subleasing right-of-use assets (included within cash flow from operating activities)

 

0.9

 

0.1

Cash flow for repayments of interest on lease liabilities (included within cash flow from operating activities)

 

–1.3

 

–1.0

Cash flow for repayments of the principal portion on lease liabilities (included within cash flow from financing activities)

 

–10.4

 

–8.9

Total cash flow

 

–13.0

 

–11.4